Repository logo
 

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (Mtb). Whilst a functional role for humoral immunity in Mtb protection remains poorly defined, previous studies have suggested that antibodies can contribute towards host defense. Thus, identifying the critical components in the antibody repertoires from immune, chronically exposed, healthy individuals represents an approach for identifying new determinants for natural protection. In this study, we performed a thorough analysis of the IgG/IgA memory B cell repertoire from occupationally exposed, immune volunteers. We detail the identification and selection of a human monoclonal antibody that exhibits protective activity in vivo and show that it targets a virulence factor LpqH. Intriguingly, protection in both human ex vivo and murine challenge experiments was isotype dependent, with most robust protection being mediated via IgG2 and IgA. These data have important implications for our understanding of natural mucosal immunity for Mtb and highlight a new target for future vaccine development.

Description

Funder: Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)

Journal Title

NPJ Vaccines

Conference Name

Journal ISSN

2059-0105
2059-0105

Volume Title

8

Publisher

Springer Science and Business Media LLC

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) (571-000-030-720, INV-038660, INV-038660)
National Natural Science Foundation of China (National Science Foundation of China) (81661128044, 81661128044)